{"id":334,"date":"2015-12-28T09:14:26","date_gmt":"2015-12-28T15:14:26","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=334"},"modified":"2018-04-23T11:44:25","modified_gmt":"2018-04-23T16:44:25","slug":"xarelto-blood-thinner-medication-update","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/","title":{"rendered":"Xarelto Blood Thinner Medication Update"},"content":{"rendered":"<p>Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there has not been a recall of the drug, a number of plaintiffs have <a href=\"http:\/\/blogs.wsj.com\/pharmalot\/2014\/08\/29\/the-clot-thickens-lawyers-boost-spending-to-solicit-xarelto-lawsuits\/\" target=\"_blank\">filed<\/a> lawsuits alleging that they experienced severe complications as a result of taking Xarelto.<\/p>\n<p>According to the plaintiffs&#8217; complaints, Xarelto caused uncontrollable bleeding to occur. The medication is designed to disrupt blood clotting patterns to prevent strokes from occurring, but it lacks an antidote to prevent any incidences of bleeding from becoming life-threatening. The plaintiffs alleged that the manufacturer did not properly warn against the dangerous risk of bleeding episodes and the inability to stop them once they start.<\/p>\n<p>Instead, the manufacturer advertised Xarelto as being safe and providing a more convenient solution than wafarin, another drug prescribed to combat blood clots and strokes. Unlike Xarelto, however, wafarin has a known antidote that doctors can use to stop bleeding episodes. In reality, Xarelto has been associated with a number of devastating and life-threatening conditions, including gastrointestinal bleeding, brain hemorrhages, strokes, and death.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/#more-334\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there has not been a recall of the drug, a number of plaintiffs have filed lawsuits alleging that they experienced severe complications as a result of taking Xarelto. According to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-334","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xarelto Blood Thinner Medication Update &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 28, 2015<\/title>\n<meta name=\"description\" content=\"Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there &#8212; December 28, 2015\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Xarelto Blood Thinner Medication Update &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 28, 2015\" \/>\n<meta name=\"twitter:description\" content=\"Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there &#8212; December 28, 2015\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xarelto Blood Thinner Medication Update &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 28, 2015","description":"Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there &#8212; December 28, 2015","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/","twitter_card":"summary_large_image","twitter_title":"Xarelto Blood Thinner Medication Update &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 28, 2015","twitter_description":"Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there &#8212; December 28, 2015","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Xarelto Blood Thinner Medication Update","datePublished":"2015-12-28T15:14:26+00:00","dateModified":"2018-04-23T16:44:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/"},"wordCount":525,"articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/","url":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/","name":"Xarelto Blood Thinner Medication Update &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 28, 2015","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2015-12-28T15:14:26+00:00","dateModified":"2018-04-23T16:44:25+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Xarelto,\u00a0a drug commonly used to treat strokes and to prevent blood clots, has come under fire for the severe risks it poses to patients. Although there &#8212; December 28, 2015","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-blood-thinner-medication-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Xarelto Blood Thinner Medication Update"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=334"}],"version-history":[{"count":3,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/334\/revisions"}],"predecessor-version":[{"id":2213,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/334\/revisions\/2213"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}